CNS Pharmaceuticals, Inc. (CNSP) › Operating IncomeCNS Pharmaceuticals, Inc. (CNSP) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$881.8K2019: -$3.83M2020: -$9.45M2021: -$14.49M2022: -$15.27M2023: -$18.87M2024: -$14.90M2025: -$15.99M-$15.99M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$15.99M-7.3%2024-$14.90M+21.0%2023-$18.87M-23.6%2022-$15.27M-5.4%2021-$14.49M-53.2%2020-$9.45M-146.7%2019-$3.83M-334.7%2018-$881.8K—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share